5701 - 5725 of 9037 Results
Title
Year
-
OPENTitle: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 4Start Page: e208033End Page: e208033Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11383879/pdf/WNL-2023-001997.pdfCitation Count: 23
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 146
-
OPENTitle: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 1Start Page: 32End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4222Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2786605/jamaneurology_gonzalez_2021_oi_210074_1643670411.5671.pdfCitation Count: 99
-
OPENTitle: Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and frameworkJournal Name: Frontiers in Systems BiologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page: 1351555End Page: 1351555Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fsysb.2024.1351555Best OA location URL: https://www.frontiersin.org/articles/10.3389/fsysb.2024.1351555/pdf?isPublishedV2=FalseCitation Count: 9
-
OPENTitle: Associations between Sleep Disorders and Impulsive-Compulsive Behaviors in Parkinson’s Disease: A Prospective Cohort StudyJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 58Issue #: 4Start Page: 256End Page: 263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000536555Best OA location URL: https://doi.org/10.1159/000536555Citation Count: 5
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page: 1435693End Page: 1435693Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Best OA location URL: https://doi.org/10.3389/fdgth.2024.1435693Citation Count: 6
-
OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 8
-
OPENTitle: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 12Start Page: 2285End Page: 2291Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30019Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30019Citation Count: 28
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01170-2/pdfCitation Count: 3
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Best OA location URL: https://doi.org/10.3233/jpd-240213Citation Count: 9
-
OPENTitle: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers InitiativeJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1185End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15091185Best OA location URL: https://www.mdpi.com/2073-4425/15/9/1185/pdf?version=1725960166Citation Count: 8
-
OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 178End Page: 178Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://www.nature.com/articles/s41531-024-00789-w.pdfCitation Count: 37
- Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis2024OPENTitle: Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 3Start Page: e200222End Page: e200222Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1212/nxi.0000000000200222Best OA location URL: https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200222Citation Count: 10
-
OPENTitle: Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical MeasuresJournal Name: Journal of Alzheimer's Disease ReportsPublisher: SAGE PublicationsVol: 8Issue #: 1Start Page: 1361End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/adr-240110Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease-reports/adr240110?id=journal-of-alzheimers-disease-reports%2Fadr240110Citation Count: 2
-
OPENTitle: Comparing machine learning and deep learning models to predict cognition progression in Parkinson's diseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 11Start Page: e70066End Page: e70066Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/cts.70066Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70066Citation Count: 8
-
OPENTitle: The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 16Issue #: 772Start Page: eadl1535End Page: eadl1535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adl1535Best OA location URL: https://www.science.org/doi/pdf/10.1126/scitranslmed.adl1535?download=trueCitation Count: 14
-
OPENTitle: In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 6Start Page: 2075End Page: 2092Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae404Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae404/61249433/awae404.pdfCitation Count: 7
-
OPENTitle: “Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients”Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page: 1648End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14231Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14231Citation Count: 0
-
OPENTitle: Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 202End Page: 202Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00805-zBest OA location URL: https://www.nature.com/articles/s41531-024-00805-z.pdfCitation Count: 5
-
OPENTitle: Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 201End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00809-9Best OA location URL: https://www.nature.com/articles/s41531-024-00809-9.pdfCitation Count: 3
-
OPENTitle: Medication recommendation for Parkinson’s disease based on dynamics of symptom progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 25051End Page: 25051Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-76941-6Best OA location URL: https://www.nature.com/articles/s41598-024-76941-6.pdfCitation Count: 2
- Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s disease2024RESTRICTEDTitle: Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 11Start Page: 3702End Page: 3713Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae303Citation Count: 25
-
OPENTitle: Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 62Issue #: 9Start Page: 11560End Page: 11571Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-025-04996-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-025-04996-1.pdfCitation Count: 3
-
OPENTitle: Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 219End Page: 219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00831-xBest OA location URL: https://www.nature.com/articles/s41531-024-00831-x.pdfCitation Count: 7
-
OPENTitle: Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and HyposmiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 2Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14244Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14244Citation Count: 11